Sarcoma News

Sarcomas are the most common tumors in young adults, and they account for 15% of all pediatric cancers.

Holocaust survivors exposed to a variety of severe deprivations demonstrated a small, but consistent, increase in cancer risk, according to results of a nationwide cohort study conducted in Israel.

The Sarcoma Foundation of America and Sarcoma Alliance last year petitioned to declare July as Sarcoma Awareness Month.

Cancer death rates appeared higher in rural than urban areas despite lower overall cancer incidence in rural areas, according to data from the CDC published in Morbidity and Mortality Weekly Report.

The FDA granted 510(k) clearance to the Halcyon treatment system for use with image-guided volumetric intensity modulated radiotherapy, according to the device’s manufacturer.

The FDA cleared the expanded use of the DigniCap Cooling System to reduce hair loss during chemotherapy to include all patients with solid tumors.

Former Vice President Joe Biden and his wife, Jill Biden, PhD, launched the Biden Cancer Initiative today.

The FDA granted orphan drug designation to tazemetostat for the treatment of patients with soft tissue sarcoma, according to the drug’s manufacturer.

Tuya Pal, MD, has been appointed associate director of cancer health disparities at Vanderbilt-Ingram Cancer Center.

This year’s ASCO Annual Meeting, held June 2-6 in Chicago, featured the theme “Making a Difference in Cancer Care With You.”